Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

U.S. Bioscience signs CRADA for novel AIDS drug

Jan. 7, 1998

Progenics reports new insights into HIV binding mechanisms

Jan. 7, 1998

HMR discloses new anti-HIV agents

Dec. 31, 1997

Triangle Pharmaceuticals plans to reinitiate trials with DMP-450

Dec. 29, 1997

Alferon evaluated in patients coinfected with HIV and HCV

Dec. 29, 1997

Enzo's HIV gene therapy nears clinical testing

Dec. 24, 1997

Sustiva trials now open to more AIDS patients

Dec. 23, 1997

Leukine boosts immune system in HIV-positive patients

Dec. 19, 1997

Itraconazole maintenance therapy prevents relapse of histoplasmosis in AIDS

Dec. 16, 1997

Promising results reported from phase II trial for AIDS-related diarrhea

Dec. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...